NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Nektar Therapeutics (NQ: NKTR)
19.86 USD  -0.44 (-2.17%)
Official Closing Price  /  Updated: 5:02 PM EST, Dec 5, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,113,009
Open 20.23
Bid (Size) 19.71 (3)
Ask (Size) 20.55 (3)
Prev. Close 20.30
Today's Range 19.80 - 20.50
52wk Range 15.63 - 47.11
Shares Outstanding 171,402,476
Dividend Yield N/A
Performance
YTD
-41.96%
-41.96%
1 Month
+7.53%
+7.53%
3 Month
+17.10%
+17.10%
6 Month
-40.96%
-40.96%
1 Year
-47.74%
-47.74%
Top News
More News
Nektar Appoints John Northcott as Chief Commercial Officer
Nektar Therapeutics (NASDAQ:NKTR) announced today that John Northcott has joined the company in the newly-created position of Senior Vice President and Chief Commercial Officer. John will also serve as... Read More
from PR Newswire
Nektar to Webcast Presentation at Jefferies 2019 London Healthcare Conference
Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to present at the upcoming Jefferies 2019 Healthcare Conference in London on Wednesday, November 20, 2019 at 4:00 p.m. Greenwich Mean... Read More
from PR Newswire
More News
Read More
Biotechs Seek Advancements In The Immuno-Oncology Field For Childhood Brain Tumors
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors
from PR Newswire
Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology
from PR Newswire
Nektar Therapeutics Presents New Clinical and Preclinical Data from its Immuno-Oncology Pipeline at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
from PR Newswire
January 2020 Options Now Available For Nektar Therapeutics (NKTR)
category Stocks
from Market News Video
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019
from PR Newswire
Friday's ETF Movers: FBT, ILF
category ETFs
from ETF Channel
Can This Biotech Improve On Bristol-Myers' Blockbuster Cancer Drug?
from Investor's Business Daily
Interesting NKTR Put And Call Options For December 27th
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.